Developing 21st Century Medicines
Theo Godfrey
Strategic Advisory and Patient Engagement Board Member
CORPORATE AND LIFE SCIENCES LEADERSHIP
Partner, Corporate Group, CMS
Advises on mergers and acquisitions, private equity, venture capital and joint ventures
Particular focus on life sciences and healthcare transactions
Co-manager, CMS equIP programme for early- and growth-stage businesses
PATIENT ADVOCACY AND STRATEGIC ENGAGEMENT
Advocate for research and funding for rare paediatric diseases
Experience supporting life-sciences companies, investors and management teams
Expertise in corporate strategy, partnerships and company development
Theo Godfrey is a corporate and venture capital lawyer with extensive experience advising companies, investors and management teams on complex transactions and strategic growth. He is a Partner in the Corporate Group at CMS, where he has a particular focus on the life sciences and healthcare sectors.
Mr. Godfrey advises private and publicly listed companies on acquisitions, disposals, private equity and venture capital transactions and joint venture arrangements. His work spans established international companies, growing businesses, institutional investors, high-net-worth individuals and management teams.
He also co-manages CMS’s equIP programme, which supports promising early- and growth-stage companies as they develop their businesses, secure investment and prepare for future expansion. Through this work, he contributes practical understanding of the legal, commercial and financing challenges faced by innovative companies.
Alongside his professional expertise, Mr. Godfrey is an advocate for increased research, investment and therapeutic development for rare paediatric diseases.
At SMDG, Mr. Godfrey contributes expertise in corporate law, life-sciences transactions, venture capital, strategic partnerships and rare-disease advocacy as a member of the Strategic Advisory and Patient Engagement Board.